Reporting Visual Acuities

Jan 6, 2017 by in OPHTHALMOLOGY Comments Off on Reporting Visual Acuities

The AJO encourages authors to report the visual acuity in the manuscript using the same nomenclature that was used in gathering the data provided they were recorded in one of…

read more

Reply

Jan 6, 2017 by in OPHTHALMOLOGY Comments Off on Reply

We thank Drs Uzun and Pehlivan for the comments. We have excluded individuals who have significant systemic diseases that could affect their visual performance, and this includes those with multiple…

read more

Reply

Jan 6, 2017 by in OPHTHALMOLOGY Comments Off on Reply

We thank Drs Hafezi and Kling for their comments regarding our recent publication. Despite intensive medical treatment being used, moderate to severe infectious keratitis usually leads to visual loss. The…

read more

Photoactivated Chromophore for Moderate to Severe Infectious Keratitis as an Adjunct Therapy: A Randomized Controlled Trial

Jan 6, 2017 by in OPHTHALMOLOGY Comments Off on Photoactivated Chromophore for Moderate to Severe Infectious Keratitis as an Adjunct Therapy: A Randomized Controlled Trial

Kasetsuwan and associates recently published a randomized clinical trial on the use of PACK (Photoactivated chromophore for keratitis) cross-linking (CXL) for moderate to severe infectious keratitis. The authors compared 2…

read more

Reply

Jan 6, 2017 by in OPHTHALMOLOGY Comments Off on Reply

We appreciate Hanumunthadu and associates’ interest in our recently published manuscript, “Response of pigment epithelial detachment to anti–vascular endothelial growth factor treatment in neovascular age-related macular degeneration.” They have presented…

read more

Response of Pigment Epithelial Detachment to Anti–Vascular Endothelial Growth Factor Treatment in Age-Related Macular Degeneration

Jan 6, 2017 by in OPHTHALMOLOGY Comments Off on Response of Pigment Epithelial Detachment to Anti–Vascular Endothelial Growth Factor Treatment in Age-Related Macular Degeneration

We read with great interest the article describing treatment response of pigment epithelial detachment (PED) to anti–vascular endothelial growth factor (anti-VEGF) treatment in neovascular age-related macular degeneration (nAMD) by Cho…

read more

Reply

Jan 6, 2017 by in OPHTHALMOLOGY Comments Off on Reply

We thank Drs Dan and Mihai Călugăru for their interest and comments regarding our recent publication titled “Conversion to aflibercept after prior anti-VEGF therapy for persistent diabetic macular edema.” As…

read more

Outcomes of Vogt-Koyanagi-Harada Disease: A Subanalysis From a Randomized Clinical Trial of Antimetabolite Therapies

Jan 6, 2017 by in OPHTHALMOLOGY Comments Off on Outcomes of Vogt-Koyanagi-Harada Disease: A Subanalysis From a Randomized Clinical Trial of Antimetabolite Therapies

Purpose To report outcomes of Vogt-Koyanagi-Harada (VKH) disease from a clinical trial of antimetabolite therapies. Design Subanalysis from an observer-masked randomized clinical trial for noninfectious intermediate, posterior, and panuveitis. Methods…

read more
Get Clinical Tree app for offline access